GPC3 expression is often silent or decreased in ovarian cancer except clear cell carcinoma types [99], as well as in mesothelioma [66], breast cancer [72], lung adenocarcinoma [71,100], and clear cell renal carcinoma. The gene discussed is GPC3; the disease is breast cancer.